SR Labs Healthcare

What SR Labs Healthcare does

SR Labs Healthcare was an Italian for-profit reseller and distribution partner, headquartered in Milano and founded in 2001, operating with 1–10 employees. Its sole function was to act as the authorized Italian channel for Tobii Dynavox's augmentative and alternative communication (AAC) products, distributing touch-based and eye-control communication devices to individuals in Italy with conditions such as ALS, autism, and cerebral palsy, along with their families, caregivers, and referring healthcare providers. The company did not develop proprietary technology; its value-add was local market access, language-localized support, customer onboarding, and ongoing service for a niche end-user base that requires high-touch, customized assistive technology deployment.

Commercially, SR Labs operated as a single-product-line, single-supplier hardware reseller with revenue derived from margins on Tobii Dynavox device and software sales. Pricing was quote-based and not publicly disclosed, and the go-to-market relied on direct customer engagement supplemented by healthcare provider referrals. The company served no enterprise accounts at scale, had no proprietary products, no AI/ML capability, no patents, no certifications, and no independent funding history. It was effectively a sales and support subsidiary in form-function, despite being an independent legal entity.

On April 1, 2026, Dynavox Group AB (the Swedish parent of Tobii Dynavox, Nasdaq Stockholm: DVX) completed the acquisition of SR Labs Healthcare for EUR 4.2 million in cash, after announcing the deal on December 23, 2025. The transaction terminated SR Labs' status as an independent Italian reseller, converting it into a direct subsidiary of the AAC manufacturer and eliminating the supplier-concentration risk that defined the standalone business.

Name

SR Labs Healthcare

Legal name

SR Labs Healthcare

Website

https://srlabshealthcare.it

Company type

Private

Founded year

2001

Operating status

Acquired

Headcount range

1–10 employees

Short description

SR Labs Healthcare was an Italian reseller of Tobii Dynavox assistive communication devices serving people with disabilities in Italy, operating as the brand's authorized local distribution and support partner until its April 2026 acquisition by Dynavox Group for EUR 4.2 million.

Ownership category

akta.pro rank

Product category

Assistive Communication Devices

NAICS

Services for the Elderly and Persons with Disabilities (624120)

akta.pro primary industry

AAC (Augmentative & Alternative Communication) Devices, Apps & Training (EDAKAIAB)

akta.pro secondary industries

AAC (Augmentative & Alternative Communication) & Speech/Language Therapy Tech (EDAFAKAB), Autism Communication Support (AAC, Pragmatics & Language) (EDAKAKAG), Assistive Technology (AT) & AAC Services (EDAJAKAF)

Keywords

• Assistive communication devices
• AAC solutions
• Eye-control technology
• Disability communication aids
• Tobii Dynavox reseller

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Resale of Tobii Dynavox AAC Solutions: SR Labs Healthcare generated revenue as a reseller of Tobii Dynavox assistive communication products in Italy, earning margins on hardware and software solution sales to end-user customers with disabilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

SR Labs Healthcare was the authorized Italian reseller and distribution partner for Tobii Dynavox's AAC (Augmentative and Alternative Communication) solutions. The company distributed touch-based and eye-control communication devices to people with communication disabilities in Italy, including individuals with ALS, autism, cerebral palsy, and other conditions resulting in communication impairment.

Product overview

SR Labs Healthcare was a reselling partner of Tobii Dynavox assistive communication solutions in Italy. The company distributed AAC (Augmentative and Alternative Communication) products, including touch-based and eye-tracking solutions, to people with disabilities in the Italian market. On April 1, 2026, SR Labs Healthcare was acquired by Dynavox Group for EUR 4.2 million, transitioning from a reseller to a direct subsidiary. No specific SR Labs Healthcare-branded products, modules, or distinct product portfolio details are available in the source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Tobii Dynavox AAC Solutions (Italian Resale)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Dynavox Group (Tobii Dynavox)coreStrategic or Co-development Partner · 1 April 2026SR Labs Healthcare was the authorized reselling partner of Tobii Dynavox in Italy for assistive communication solutions. The partnership involved distributing Tobii Dynavox's AAC (augmentative and alternative communication) products including touch-based and eye-control communication devices to people with disabilities in the Italian market. Dynavox Group acquired SR Labs Healthcare on April 1, 2026 for EUR 4.2 million to strengthen direct access to the Italian market.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Emerging players

• Jabbla: Belgian AAC device manufacturer (Mobi, Tellus, Sensory Series) competing with Tobii Dynavox across touch and eye-gaze categories, often relying on country-level resellers similar to SR Labs in select EU markets.
• AssistiveWare: Apple-platform-native AAC app maker (Proloquo2Go, Proloquo4Text) serving the iOS-software-based AAC segment that overlaps the touch-based half of Tobii Dynavox's portfolio SR Labs distributed.
• Control Bionics: Australia/Canada-listed AAC company with the NeuroNode and Neuronode Duo platforms combining EMG and eye tracking, an emerging alternative in the high-end AAC space where SR Labs and Tobii Dynavox compete.
• Smartbox AT: UK-based AAC device and software maker (Grid, Eye-Gaze technologies) that competes with Tobii Dynavox's eye-control portfolio and would also typically partner with regional resellers in markets like Italy to localize distribution.

Regional players

• Liberator Ltd: Australia-based AAC distributor (PRC-Saltillo device reseller) with a geographic split but identical channel-reseller economics to SR Labs, providing a useful regional comp for the Italian Tobii Dynavox model.

Direct peers

• Eyegaze Inc. US eye-tracking AAC device seller and integrator with a comparable niche distribution model to SR Labs, specializing in eye-gaze communication solutions for individuals with severe physical disabilities.
• Talk To Me Technologies: US-based AAC reseller and speech-generating device distributor with a comparable channel model to SR Labs, working with multiple device manufacturers including Tobii Dynavox to serve individuals with communication disabilities.
• Forbes AAC: US AAC equipment and speech device reseller/distributor with a near-identical business model to SR Labs: multi-channel sales of devices from leading AAC manufacturers to end users, families, and clinical referrers.

Broad incumbents

• Tobii Dynavox (Dynavox Group): Global AAC device manufacturer and SR Labs's principal product supplier, now also its parent company following the April 2026 acquisition. Provides the same touch and eye-gaze AAC solutions SR Labs distributed, vertically integrating the Italian channel.
• PRC-Saltillo: Leading AAC device manufacturer (ChatPlus, NOVA chat, TouchChat) with a hybrid model that competes with Tobii Dynavox via direct sales and via the Liberator subsidiary in markets like Australia/UK - directly substitutable for the products SR Labs sold.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SR Labs Healthcare